Sigma Institute of Pharmacy, Sigma University, Bakrol, Vadodara-390019, Gujarat.
Nanotechnology has revolutionized modern science through its ability to manipulate materials at the molecular and atomic levels, leading to significant advancements in drug delivery, diagnostics, and therapeutic applications. This review provides an overview of important nanomaterials such as solid lipid nanoparticles (SLNs), nanogels, nano-emulsions, and nanoparticles, emphasizing their classification, synthesis, and biomedical relevance. These nanoscale systems exhibit unique physicochemical properties—including enhanced solubility, targeted delivery, biocompatibility, and controlled release—making them ideal for pharmaceutical applications. Nanogels, for example, demonstrate responsiveness to environmental stimuli, offering promise in gene therapy and cancer treatment. Similarly, nano-emulsions enhance the bioavailability of hydrophobic drugs, while SLNs serve as efficient carriers for poorly soluble therapeutic agents. The integration of organic, inorganic, and carbon-based nanoparticles has expanded the scope of nanomedicine, enabling more precise and efficient therapeutic outcomes. Despite the remarkable progress, challenges such as large-scale production, stability, and toxicity remain barriers to clinical translation. This article summarizes the recent developments and applications of key nanomaterials and provides insights into their future prospects in drug delivery and biomedical sciences.
Introduced in 1991, solid lipid nanoparticles (SLN) are an alternative to conventional colloidal carriers like emulsions, liposomes, and polymeric micro and nanoparticles. Solid-based nanoparticles are garnering significant interest as a novel colloidal drug carrier for intravenous applications because they have been suggested as an alternative particulate carrier system. Sub-micron colloidal carriers (SLN) are made of physiological lipid and are distributed in water or an aqueous surfactant solution. They have a diameter of 50 to 1000 nm. Small size, high drug loading, vast surface area, and phase interaction at the interface are some of the special qualities that SLN offer. They are also appealing because of their potential to enhance pharmacological performance [36]. SLNs have a mean diameter of 50–1000 nm and are morphologically spherical, smooth surfaces. Both behaviors in vitro and in vivo rely on how SLNs are physicochemically characterized (Fig. 1)[1].
Fig. 1: Structure of SLNs [1]
Nano-formulations include drug particles at the nanoscale that are made with nanotechnology or have been integrated with nano-formulations to provide a revolutionary drug delivery system. In the 1960s, nano-formulation began to be used in the pharmacological and medical domains (fig. 2) [3].
Fig.2: The historical development of nano-formulations [3]
A very versatile family of nanocarriers, lipid-based nanoparticles (LNAPs) have become widely used in pharmacology and medical research [4]. The main obstacle to medication administration in the posterior portion is the blood-retinal barrier. The most popular and straightforward method of delivering medication to the anterior segment is topical administration, similar to eye drops [4]. Nanoemulsions (NEs) are colloidal dispersions that are nanometers in size. They usually consist of an oil phase that is dispersed in an aqueous phase (oil-in-water, O/W) or vice versa (water-in-oil, W/O). Bicontinuous and multiple NEs (MNEs) are examples of additional categories, such as oil-in-water (O/W/O) or water-in-oil-in-water (W/O/W) [21]. In the nanoscale size range, nanogels are three-dimensional hydrogel materials made of networks of crosslinked, swellable polymers that have a high capacity to retain water without truly dissolving in the aqueous medium. Their architecture's adaptability permits the addition of a wide variety of guest molecules, from inorganic nanoparticles to biomacromolecules like proteins and DNA, with the appropriate adjustments to the materials used in their production, all without affecting their gel-like properties [34]. Nanogels (NGs) for drug delivery, gene therapy, and nanohydrogels have been developed as a result of recent developments in nanomedicine. They are appropriate for biomedical applications since they are frequently biocompatible. Hydrogels come in a wide range of sizes, from a few micrometers to several centimeters, and are employed in a variety of fields, including bandages, tissue engineering, cosmetics, and medical equipment[26]. There are currently only 15 cancer medications based on nanoparticles available on the market, compared to decades before. Limited scalability, inadequate control over reaction parameters, nanoparticle polydispersity, inadequate batch-to-batch repeatability, and high chemical reagent volumes—including pharmaceuticals—are the hurdles in nanoparticle translation[26]. Depending on their intended uses and desired characteristics, nanogels can be made of a wide range of natural or synthetic polymers. The following are examples of natural polymers: (a) chitosan, which is derived from chitin and is known for its antimicrobial, biocompatible, and biodegradable qualities; (b) alginate, which is extracted from algae and is valued for its ability to form gels in the presence of divalent ions like calcium; (c) hyaluronic acid, which is a naturally occurring component of the extracellular matrix and is chosen for its highly effective water retention; and (d) polysaccharides, such as those found in natural gums[23].
Nanogels are non-toxic to the tissue microenvironment and exhibit extremely high stability in physiological fluids[26] Because of their robustness and similarity to human tissues, they are able to withstand shear forces and blood serum proteins. Table 1 lists the most current systems based on nanogel technology, demonstrating its multifunctional qualities that are beneficial for a range of illnesses [26].
Table 1: Recent advancements in nanogels used for various diseases [26]
|
Sr. no |
Nanogel Matrix Materials |
Synthesis Method |
Imaging Agent |
Therapeutic Delivered |
Disease |
|
1 |
Polysulfamide-based poly[2-((2-(methacryloyloxy)ethyl)dimethylammonio) acetyl)(phenylsulfonyl)amide (PMEDAPA) nanogels |
Aqueous precipitation polymerization |
Fluorescent dye Cy5-modified PMEDAPA nanogels are used to visualize the behaviours of nanogel |
Doxorubicin hydrochloride (DOX) |
Cancer therapy |
|
2 |
Dual enzymes lactate oxidase (LOD) and catalase (CAT) encapsulated into the self-assembled nanogels to fabricate responsive nanoprobes LOD/CAT-loaded nanogels (LCNGs) |
Supramolecular chemistry |
Enzymes substrates |
— |
— |
|
3 |
Gold NGs (GAuNGs) composed of thermoresponsive linear poly(glycidyl ether)(tPG) chains cross-linked by small AuNPs |
Thermo-nanoprecipitation |
NIR absorption capable GAuNGs |
(DOX) |
— |
|
4 |
Near infrared (NIR)-responsive CuS?-loaded nanogels |
Reflux-precipitation polymerization |
CuS/Cy-7 |
(DOX) |
— |
|
5 |
Zwitterionic nanogels based on poly(sulfobetaine methacrylate) (PSBMA) |
One-step reflux-precipitation polymerization |
— |
Levofloxacin (LEV) |
Ophthalmology application |
|
6 |
Penetratin-complexed, redox-responsive hyaluronic acid-based nanogels |
EDC coupling protocol |
Carbon dots (CD) |
9-cis-Retinal |
— |
|
7 |
NIR activable biomimetic ARNGs@TMZ/ICG nanogel |
Cross-linking by pullulan and poly(deca-4,6-diynedioic acid)(PDDA) and loaded with temozolamide and indocyanine green (ICG) |
Green fluorescence labelled CD31 antibody used to absorb penetration of nanogels into the tumor |
Temozolamide and indocyanine green (ICG) |
Neurological disorders |
|
8 |
A jelly formulation containing M. pruriens seed-extract nanogel |
Ionic gelation |
— |
Levodopa (L-dopa) |
— |
|
9 |
Sulfated nanogels (NGs) based on dendritic polyglycerol sulfate (dPGS) |
Inverse nanoprecipitation technique based on a bio-orthogonal click reaction |
— |
Potent inhibitors for HS-binding viruses |
Anti-viral application A |
Classification
1. Solid-Lipid Nanoparticles (SLNs)
Three major forms of SLNs can be distinguished based on drug loading: [40,41]
Fig:3 A) Homogenous matrix, B) Drug-enriched shell, C) Drug-enriched core [40,41]
Through careful formulation procedures like high-pressure homogenization above the lipid melting point or cold homogenization methods, the homogeneous matrix model exhibits a uniform distribution of drug molecules spread throughout the solid lipid core. In addition to improving therapeutic efficacy and stability by avoiding crystallization or phase separation, this strategy guarantees consistent drug encapsulation and controlled sustained release. It is especially well-suited for uses that call for enhanced bioavailability and sustained pharmacological activity. Conversely, the outer shell of the nanoparticles is where the drug is mostly concentrated in the drug-enriched shell model. While the drug becomes enriched and trapped in the solid-lipid outer shell, which subsequently hardens and encapsulates the drug on the surface, the lipid core of a hot lipid nano-emulsion initially solidifies during cooling. Although it might not be as suitable for prolonged release, this design offers quick or burst release, which is beneficial in situations requiring focused administration or an instant therapeutic effect. The inner core of the nanoparticles contained a high concentration of the drug, according to the drug-enriched core model. Before lipid recrystallization, drug molecules precipitate inside the lipid matrix when it cools, creating a drug-rich core encased in a protective lipid shell. By demonstrating drug diffusion across the lipid barrier, this arrangement protects delicate medications and offers extended, regulated release. It is perfect for treatments that call for prolonged drug release patterns and defense against degradation of the active ingredient; see figure 4. [40, 41, 52, 50]
2. Nanogels
The classification of nanogels is mentioned in Fig. 4[24]
Fig:4 classification of nanogels [24]
1. Nanogels are categorized based on their structural properties.
Fig. 5 lists the different kinds of nanogels. [24]
Fig:5 types of nanogels based on structure [24]
An empty core cavity is part of the structure of hollow nanogels. Core-shell particles (such as silica, gold, and HPC) are used in the creation of hollow nanogels, and the core is then removed (either by solvent precipitation or a pH gradient). Large surface area and a hollow interior for loading or trapping are two benefits of hollow nanogels.
Multiple layers of one or more polymers make up the structure of these nanogels. Sequential polymer layering, occasionally with crosslinking, is the preparation method. Its benefits include a high site specificity, a customizable drug release profile, and suitability for highly potent or fragile medications.
Metal, a nanorod, and a carbon-based nanomaterial make up the structure. The polymeric or organic shell encloses the center. Functional characteristics like optical, magnetic, and conductive are provided by the core, while the shell manages stability and release.
This nanogel's structure consists of surface-grafted, hair-like polymer chains, sometimes referred to as polymer brushes. It is prepared via controlled radical polymerization techniques or macro-RAFT agents [24].
2. Nanogels are categorized according to how responsive they are to different environmental stimuli.
3. Linkage-based nanogels:
Ionic, surface/interface, adsorption, and van der Waals forces are examples of self-assembled interactions that don't require cross-linking agents. They don't need chemical reagents to lessen toxicity because this kind of connection is reversible. It enables regulated release and dynamic responses. However, it is unstable and quite weak. For example, micellar nanogels, liposome-modified nanogels, and physically cross-linked nanogels.
Its stable bonds indicate that the coupling is stoichiometrically controlled and permanent. They have stable structures and a high mechanical strength. Their qualities are precisely tuned and they are resilient. Additionally, they are helpful for stimuli-responsive or regulated release.
4. Polymer-based nanogels:
Drug delivery systems based on oligosaccharide-based nanogels are becoming more popular due to their safety, biodegradability, and ease of modification. Usually created by the interaction of naturally occurring polymers with positive and negative charges, they are able to react to variations in the pH of the body. For example, without the need for additional surfactants, chitosan nanogels serve as natural emulsion stabilizers. They can also be cross-linked to increase their stability for medicinal applications. Pullulan nanogels are useful in drug and protein delivery because they are very effective at preventing proteins from clumping or breaking down, especially when modified with cholesterol[37,38].
Particularly intriguing are hyaluronic acid (HA) nanogels, which have the inherent capacity to target particular cells due to their natural binding to the CD44 receptor, which is present on the surface of many cells. Alginate nanogels are especially effective in protecting delicate proteins during oral delivery, even in the stomach's acidic environment, and they may be chemically altered to change how they dissolve. Utilizing its donut-like shape, cyclodextrin nanogels enhance the solubility of hydrophobic medicinal molecules by trapping and transporting them. Last but not least, gum acacia nanogels, which are derived from the natural gum of acacia trees, are affordable, environmentally benign, and extremely soluble in water. As such, they may be readily combined with other polymers, such as chitosan, to deliver drugs. All things considered, these various varieties of polysaccharide nanogels demonstrate how natural materials can be transformed into an excellent instrument for safer, more effective, and targeted treatments. [43]
3. Nanoemulsions
Types of Nanoemusion: [44,52]
Emulsions represent an important class of pharmaceutical dosage forms in which one liquid is dispersed as small droplets within another immiscible liquid, stabilized with the aid of emulsifying agents. Their significance in pharmacy arises from their ability to improve drug solubility, mask unpleasant taste, enhance absorption, and permit controlled drug release. pharmaceutical emulsions may be oil-in-water(O/W) or water-in-oil (W/O), with their application ranging from oral, topical, and parenteral delivery to cosmetics to conventional emulsions, advanced systems such as nanoemulsions and microemulsions have gained increasing attention due to their small droplet size, high stability, and improved bioavailability of poorly soluble drugs. [46,47]
With droplet sizes of less than 200 nm, nanoemulsions are kinetically stable but thermodynamically unstable dispersions that are primarily categorized by their composition and dispersed phase type. Oil-in-water (O/W) nanoemulsions, in which oil droplets are distributed throughout an aqueous phase, are the three main varieties.[35,36]
frequently used to increase the solubility and absorption of lipophilic drugs; bicontinuous nanoemulsions, where both the water and oil domains interpenetrate and provide benefits in solubilizing both hydrophilic and lipophilic drugs; and water-in-oil (W/O) nanoemusions, where water droplets are distributed in a continuous oil phase and are frequently used in topical, cosmetic, and transdermal applications. Each kind has distinct biological and physical characteristics that affect its stability, drug release profile, and potential for use in pharmaceuticals. Nanoemulsions are extremely adaptable carriers in modern pharmacy because they may be customized for oral, parenteral, or topical administration systems by carefully choosing the formulation components. [45,46,51,52]
4. Nanoparticles
Fig:6 classification of nanoparticles [48,49]
Nanoparticles are classified into three main types:
ONPs are made from organic compounds and are less than 100 nm. Ferritin, micelles, dendrimers, and liposomes are a few examples; many of them are hollow nanocapsules that can transport medications. Their primary benefits-biodegradability, non-toxicity, and light and heat responsiveness-make them ideal for use in biomedicine. Particle size, surface form, stability, and drug-loading techniques (entrapped or absorbed) all affect how well they transport drugs. ONPs are frequently utilized in regulated and targeted drug delivery systems due to their ability to target particular bodily areas [48,49].
Fig:7 Types of organic nanoparticles: A) Dendrimers B) Liposomes C) Micelles D) Ferritin [48]
Gold, silver, copper, iron, zinc, and cobalt are among the elements that can be used to create metal nanoparticles, which have remarkable electrical, thermal, antibacterial, and catalytic capabilities. Surface behavior is improved by their nanoscale size. These nanoparticles, which have customizable size and shape, are used in environmental sensing, chemical catalysis, and biological imaging because of their potent surface activity and quantum phenomena. [49]
Carbon-based nanoparticles have special electrical, thermal, and structural characteristics. They are made from carbon allotropes such as graphite, diamond, graphene, carbon nanotubes (CNTs), and fullerens. Their strong covalent structures and adaptable bonding enable them to be used in biological, electronics, energy storage, and water treatment applications. While CNTs and activated carbon are useful for adsorption, catalysis, and separation processes, graphene, a single-atom-thick sheet with exceptional strength and conductivity, is used as a building block for other carbon nanostructures. [48]
a) Fullerenes
Buckminsterfullerene (C60), in particular, is a spherical carbon molecule made up of 60 carbon atoms put in a cage-like structure that resembles a soccer ball. They have special physicochemical characteristics due to their symmetrical geometry and resonance stabilization. Derivatives of C60, including nanorods, nanotubes, and nanosheets, are utilized in material science, catalysis, and nanoscience. Applications in medication delivery, polymer development, and environmental cleanup are made possible by their capacity to undergo covalent and supermolecular modifications. [48,49]
Fig:8 types of carbon-based NPs: A) C 60 fullerence; B) carbon black NPs; C) carbon quantum dots [48]
b) Graphene and graphene oxide
Graphene and its derivative, graphene oxide (GO), have shown great promise in the creation of polymer-based nanocomposites because of its exceptional barrier qualities, electrical conductivity, and mechanical strength. Although pure graphene has many benefits, its large-scale use is hampered by issues including agglomeration, poor solubility, and the complexity of bottom-up synthesis. Conversely, GO is easily synthesized from carbon sources using top-down techniques, and because it contains functional groups that contain oxygen, it has great solubility and may effectively modify its surface. These characteristics improve GO dispersion in polymer matrices, which raises the overall effectiveness of nanocomposites. Furthermore, GO's sp2-hybridized carbon network effectively blocks gas diffusion, which makes it ideal for use in innovative packaging materials, corrosion resistance, and protective coatings for delicate electronics. [48]
Literature Review
|
Sr No. |
Title |
Discription |
Ref. No. |
|
1. |
Solid lipid nanoparticles: Preparation techniques, their characterization, and an update on recent studies |
Key Points: Solid lipid nanoparticles, carrier system, nanomedicine, biocompatibility, nanotechnology Nenotech Type: Nanocolloidal system for drug delivery Focus: Enhance Bioavailability Size: 0.05-1 µm |
1 |
|
2. |
Solid Lipid Nanoparticles for DrugDelivery: Pharmacological and Biopharmaceutical Aspects |
Key Points: clinical trials, drug delivery, nanostructured lipid carriers, nanotoxicity, pharmacokinetics, pharmacodynamics, routes of administration, and solid lipid nanoparticles Nenotech Type: Nanosized drug delivery systems Focus: Disposition in the Body and Penetration to the CNS, Gastrointestinal Absorption of Lipid-Nanoparticles, Systemic Circulation and Protein Corona Formation. Size: 0.001-1µm |
2 |
|
3. |
Nano?formulations in disease therapy: designs, advances, challenges, and future directions |
Key Points: Nano-formulations, Design strategies, Disease therapy, Hybrid nanoparticle Nenotech Type: Innovative drug deliverysystem Focus: malignant tumors, chronic pulmonary conditions, complex cardiovascular diseases, or refractory conditions such as diabetes, fragile ocular diseases, and recalcitrant dermatological disorders, thereby enabling more precise and effective therapeutic interventions. Size:0.01-0.2µm |
3 |
|
4. |
Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in TheirIndustrial Development |
Key Points: Manufacturing, Lipid-based nanoparticles, Delivery systems, Lipid-based nanoparticle synthesis, Industrial challenges Nenotech Type: Novel drug delivery systems Focus: Liposomes, nanostructured lipidCarriers, lipid polymer hybrid Nanoparticle. Size: SLNs 0.05-1µm Small Unilamellar Liposomes size of <1 µm |
4 |
|
5. |
Nano-formulations in pharmaceutical and biochemical applications: Green perspectives |
Key Points: Nano-therapy; Nanopharmaceuticals; biomaterials; photo-nanotheranostics; biomimetics; biomimetics; bioinspiration; cyborg cells; green design Nenotech Type: Nanomicelles, lipid-based nanoparticles, liposomes, Dendrimers, carbon nanometrials, metal-based nanopaticles, quantum dots, metal-oraganic frameworks, bio-nanopharmaceuticals Focus: Nanotechnology in pharmaceutical and biomedical applications, nanoformulations. Size: 0.01-1 µm |
5 |
|
6. |
Recent trends in nanoparticle-based drug delivery for tuberculosis treatment |
Key Points: Biodegradable, Drug delivery, Nanoparticles, Nanoencapsulation Nanotech type: Chitsan nanoparticles, PLGA nanoparicles Focus: Nanoparticles-based drug delivery system for tuberculosis treatment. Size: < 1µm |
6 |
|
7. |
Nanoparticles in drug delivery: from history to therapeutic applications |
Key Points: Drug delivery; Nanomedicine; therapeutics; Personalized medicine Nenotech type: Polymeric nanoparticles, solid-lipid nanoparticles, liposomes, nanoemulsion, metallic nanoparticles, mesoporous silica, chitosan nanoparticles, Focus: Targeted drug delivery. Size: 0.01-1 µm
|
7 |
|
8 |
Emerging Nano-formulations and nanomedicines applications for ocular drug delivery |
Key Points: Organic and inorganic nanoparticles; ophthalmic applications; clinical trials Nanotech type: liposomes, niosomes, dendrimers, inorganic nanoparticles ex; gold NPs Focus: Nanotechnology in ocular drug delivery.
|
8 |
|
9 |
Review on Nano-emulsions drug delivery system and formulation, evaluation and their pharmaceutical application |
Key points: Nano-emulsion, Types of nano-emulsion, surfactants, Novel drug delivery, pharmaceutical application Nanotech type: Novel drug delivery by nano-emulsion Focus: Advantages, limitations, basic information, all types of nano-emulsion drug delivery. Size: 0.05-5 µm |
9 |
|
10 |
Basic concepts and recent advances in nanogels as carriers for medical applications |
Key points: Nanogel, response to external stimuli, nano-carrier, drug release, physical and chemical cross linking, genetic material, protein and vaccine delivery Nanotech type: Nanogels, hydrogels particles, crosslinked polymer network at nanoscle and stimuli-responsive nanogels Focus: Nanogels as nanocarriers, how nanogels integrate in the nanomedicine and nanogels features and advantages, prepration techniques. |
11 |
|
11 |
Modern herbal nanogels: formulation, delivery methods, and applications |
Key points: nanogels; herbal bioactives; hydrogels; polysaccharides Nanotech type: Herbal-based nanogels Focus: herbal nanogels use as nanocarrriers. Size: standard Description: 1 µm Accepted Dimensions: 2 µm Frequent Range: 1-0.1 µm |
12 |
|
12 |
Advances in nanoparticles in targeted drug delivery-a review |
Key points: Nanoparticles; drug delivery; nanomedicine; biocompatibility; therapeutics Nanotech type: Physically cross-linked vs chemically cross-linked nanogels, stimuli-responsive nanogels, morphological variants Focus: Nanogels as advanced drug delivery system for dermal and transdermal routes. |
13 |
|
13 |
Hybrid hydrogels incorporating nanoparticles, their types, development, and applications; a comprehensive review of nanogels |
Key points: hydrogels, nanoparticles Nanotech type: Stimuli-responsive nanogels Focus: use of nanogels as efficient drug delivery systems for dermal and tansdermal applications. |
14 |
|
14 |
Nanogels as novel drug nacarriers for CNS drug delivery |
Key points: Nanogels, blood-brain barier, blood cerebrospinal fluid barrier, brain targeting, drug delivery, CNS Nanotech type: Stimuli-responsive, biocompatible, cross-lined polymeric nanogels for brain targeting Focus: Nanogels as novel drug nanocarriers for CNS drug delivery |
15 |
|
15 |
Nanoemulsions: summary of a decade of recent advances |
Key points: applications, emulsifiers, methods of preparation, nanoemulsion, route of administration, screenings, surfactant Nanotech type: Nanoemulsions-submicron-sized emulsions stabilized by surfactants Focus: Nanoemulsions technology. Size: typical size: less than 2 µm CNS Delivery: 0.2-2 µm |
16 |
|
16 |
Recent trends in nanoparticlesbased drug delivery for tuberculosis treatment |
Key points: Biodegradable, Drug delivery, nanoparticles, nanoencapsulation Nanotech type: Polymericnanoparticles used for sustained and targeted delivery Focus: Recent trends in nanoparticle-based drug delivery specifically for treating tuberculosis. Size: Droplet sizes: 0.2-2 µm |
17 |
|
17 |
Nanoemulsions for drug delivery |
Key points: Nanoeulsions, surfactants, drug delivery, nanomedicine, peptide surfactant Nanotech type: Novel drug-delivery Focus: Nanoemulsions, nanomedicine. |
19 |
|
18 |
Recent trends and advancements in nanoemulsions: production methods, functional properties, applications in food sector, safety and toxicological effects |
Key points: Encapsulation,food industry, nanocoating, nutrient delivery, nanotechnology Nanotech type: Nanoemulsions, nanoscale dispersions of immiscible liquids stabilized by surfactants. Focus: Nanoemulsions for enhancing functional properties and applications in the food sector. Size: 1-1 µm |
20 |
|
19 |
Advancements in nanoemulsion-based drug delivery across different administration routes |
Key points: Nanoemulsions; drug delivery; trans dermal; oral; ocular; nasal intra-articular Nanotech type: Nanoemulsions-nanoscale colloidal dispersions of oil and water stabilized by surfactants, ranging from 50 to 500 nm in droplet size. Focus: Advancements in nanoemulsion-based drug delivery across various administration routes, including (trans)dermal, oral, ocular, nasal, and intra-articular. Size: droplet size: 0.5-5 µm |
21 |
|
20 |
Nanogels: recent advances in synthesis and biomedical applications |
Key points: Nanogels; nanoparticle synthesis; hydrogels and microgels; batch chemistry; flow chemistry; microfludics; nanimedicine; theranostics; crosslinking; drug delivery Nanotech type: Nanogels nanoscale, cross-linked polymeric networks that can encapsulate drugs and respond to environmental stimuli Focus: Recent advances in the synthesis and biomedical applications of nanogels, emphasizing their versatility and promising roles in drug delivery and imaging. Size: 1-0.1 µm |
23 |
|
21 |
A comprehensive review of nanogel-based drug delivery system |
Key points: Swelling behavior, polymer, exceptional drug loading capability, drug delivery, nanogel Nanotech type: Nanogels-crosslinked, nanoscale hydrogel particles that are stimuli-responsive and capable of encapsulating therapeutic agents for targeted delivery. Focus: Comprehensive review of nanogel-based drug delivery systems, highlighting their advantages, synthesis, characterization, and therapeutic applications. Size: Parenteral: 2 µm Transdermal Delivery: below 0.5 µm Ocular Delivery: below 2 µm |
24 |
|
22 |
Biopolymer-based nanogel approach in drug delivery: basic concept and current developments |
Key points: biopolymers; nanogels; drug delivery; polysaccharide-based nanogels; protein-based nanogels; nanotechnology Nanotech type: Nanogels (polymeric hydrogel nanoparticles) Focus: Biopolymer-based nanogels in drug delivery (concepts, design, applications). |
25 |
|
23 |
Nanogels: A chemically versatile drug delivery platform |
Key points: Nanogel, Hydrogel, Polymeric nanoparticle, Crosslinked polymer, Nanocarrier, Crosslinking copolymerization, Nanopolymerization encapsulation, stimulai-responsiveness, smart material, Targeted delivery, Drug delivery, Bottom-up synthesis Nanotech type: Nanogels - crosslinked polymeric nanoparticles (nano-hydrogel networks) that can encapsulate varied payloads and respond to environmental triggers. Focus: Nanogels as a chemically versatile platform for drug delivery, highlighting their tunability, stimuli responsiveness, and potential in precision therapeutics.
|
27
|
|
24 |
Advances in nanogels for topical drug delivery in ocular diseases |
Key points: Nanogels, oscular diseases, drug delivery systems, natural polymers, contact lenses Nanotech type: Nanogels - nanoscale, crosslinked polymeric hydrogel networks used as ocular drug carriers Focus: Nanogels for topical drug delivery in ocular diseases (glaucoma, dry eye, keratitis, etc.). |
28 |
|
25 |
Nanoparticles for drug delivery: insight into in vivo and in vitro drug release from nanomedicines |
Key points: Nanoparticles, drug release, in vivo, in vitro, correlation, Nano-safety Nanotech type: Nanoparticles (including organic, inorganic, and hybrid nanoparticles). Focus: Nanoparticles for drug delivery, with special emphasis on In Vitro–In Vivo Drug Release Correlation (IVIVC) Size: less than 2 µm and formulations being around 0.6-1.1 µm |
29 |
|
26 |
Lipid-based nanoformulations for drug delivery: An ongoing |
Key points: Liposomes, SLN, targeting, controlled release, solubility enhancement, vaccine, hydrophobic peptide, self-emulsifying Nanotech type: Nanoparticles (especially surface-modified nanocarriers) Focus: Modulation of nanoparticle behavior via surface engineering for improved drug delivery performance. Size:0.2-2 µm |
31 |
|
30 |
A recent update: solid lipid nanoparticles for effective drug delivery |
Key points: solid lipid nanoparticles, (SLNs), method of preparation, route of administration, biological drugs, surface modified SLNs, patents Nanotech type: Solid Lipid Nanoparticles (lipid-based nanocarriers) Focus: Solid Lipid Nanoparticles (SLNs) for improved drug delivery (bioavailability, targeting, controlled release). Size: Nanoscale officially end at 100 nm and drug delivery system up to 0.1 µm general goal of being smaller than 0.01µm for effective cell penetration. |
32 |
|
31 |
Emulgel: An emerging novel drug delivery system |
Key points: Cosmeceuticals, Gels, Emulgel, Emulsifying agents, Emulsions, Topical drug delivery Nenotech type: Nanoemulsion-based emulgel - a nanotechnology type combining emulsions and gels for enhanced penetration and stability of herbal actives. Focus: The study focuses on improving the topical delivery of hydrophobic herbal drugs using emulgel formulations that enhance skin absorption and therapeutic efficacy. Size: 0.2-5 µm |
33 |
|
32 |
A review on self-nanoemulsifying drug delivery system |
Key points: Solubility, stability, bioavailability, hydrophobic drugs, triglycerides Nenotech type: utilizes spontaneous formation of oil-in-water nanoemulsions upon contact with gastrointestinal fluids. Focus: enhancing the solubility, stability, and bioavailability of poorly water-soluble drugs using self-nanoemulsifying drug delivery system (SNEDDS). Size: 0.2 -2 µm |
34 |
CONCLUSION
Nanotechnology represents a transformative frontier in pharmaceutical and biomedical research. Through the development of SLNs, nanogels, nano-emulsions, and various nanoparticle systems, it has become possible to design highly efficient, targeted, and controlled drug delivery platforms. These nanomaterials have demonstrated immense potential in improving therapeutic efficacy, reducing side effects, and overcoming biological barriers. Continuous advancements in formulation techniques and polymer science will further enhance the precision and safety of nanocarriers. However, addressing issues related to scalability, biocompatibility, and regulatory approval is essential for successful clinical translation. Overall, nanotechnology continues to pave the way for innovative solutions in medicine, diagnostics, and material science, promising a new era of advanced therapeutics.
REFERENCES
Khushi Prajapati, Himani Vaghasiya, Kajal Vable*, Dr. Mitali Dalwadi, Dr. Priyanka Patil, Focus on Nanotechnology: A Brief Overview of Important Nanomaterials and Their Diverse Uses, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 10, 1933-1951 https://doi.org/10.5281/zenodo.17383394
10.5281/zenodo.17383394